acoziborole

Sanofi's sleeping sickness drug cures 95% of people in phase 2/3 trial, boosting plan to stop transmission
Fierce Biotech
Wed, 11/30/22 - 10:50 am
Sanofi
sleeping sickness
acoziborole
clinical trials